DIR fees

DIR Fees: What NCPA Wants from Part DIn a letter to the CMS, DIR fees take precedence
New Report: PBMs Push Drug Costs
New Report: PBMs Push Drug CostsAre PBMs responsible for higher drug prices or is something else to blame?
Reader Response
5 Ways to Improve Medicare Part DNCPA’s recommendations for improving the “increasingly complicated Part D marketplace.”
NACDS’ New CourseExpanded scope-of-practice/health-and-wellness figure prominently in new strategy.
Pharmacists Are Flying In to Washington to Talk and PersuadeDIR fees top pharmacy legislator meetings.
Pharmacists to Descend on Washington
Pharmacists to Descend on WashingtonDIR fees and health-care reform will lead pharmacists’ legislative concerns.
DIRs: PBMs Pay Less Each Year While Prices Go UpPBMs have a business model where they pay less even while prices go up.
Pharmacists Pushing for DIR Relief
Pharmacists Pushing for DIR ReliefCommunity pharmacists fight against financial pressure for their survival.
New Legislation Aims to Prohibit DIR FeesBills have been introduced in both the Senate and House that are aimed at stopping direct and indirect remuneration fees, assuming they are passed.